Skip to content
Prednicarbate
Dermatop (prednicarbate) is a small molecule pharmaceutical. Prednicarbate was first approved as Dermatop on 1991-09-23. It is used to treat facial dermatoses, foot dermatoses, hand dermatoses, inflammation, and leg dermatoses amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
skin and connective tissue diseasesD017437
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Prednicarbate
Tradename
Company
Number
Date
Products
DERMATOP E EMOLLIENTBausch Health CompaniesN-020279 DISCN1993-10-29
1 products, RLD
DERMATOPBausch Health CompaniesN-019568 DISCN1991-09-23
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
prednicarbateANDA2018-04-12
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
facial dermatosesD005148
foot dermatosesD005533
hand dermatosesD006229
inflammationMP_0001845D007249
leg dermatosesD007868
pruritusHP_0000989D011537L29
scalp dermatosesD012536
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
D07: Corticosteroids, dermatological preparations
D07A: Corticosteroid dermatological preparations, plain
D07AC: Corticosteroids, potent (group iii)
D07AC18: Prednicarbate
HCPCS
No data
Clinical
Clinical Trials
36 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
T-cell lymphoma peripheralD016411C84.94641113
Disease progressionD01845011
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
T-cell lymphomaD0163991112
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-hodgkin lymphomaD008228C85.9323
Multiple myelomaD009101C90.0212
AdenocarcinomaD00023022
Squamous cell carcinomaD00229422
Non-small-cell lung carcinomaD002289112
Large-cell lymphoma anaplasticD017728C84.6122
Mycosis fungoidesD009182C84.0212
B-cell lymphomaD016393122
Hodgkin diseaseD006689C81222
LymphomaD008223C85.9222
Show 15 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C8033
T-cell lymphoma cutaneousD016410C84.A22
Sezary syndromeD012751C84.111
Primary cutaneous anaplastic large cell lymphomaD054446C86.611
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePREDNICARBATE
INNprednicarbate
Description
Prednicarbate is a corticosteroid hormone.
Classification
Small molecule
Drug classprednisone and prednisolone derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
Identifiers
PDB
CAS-ID73771-04-7
RxCUI34369
ChEMBL IDCHEMBL1200386
ChEBI ID
PubChem CID6714002
DrugBankDB01130
UNII IDV901LV1K7D (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 185 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
537 adverse events reported
View more details